Clinical Trials on Hazardous; Use, Alcohol in Canada

Total 329 results

University of British Columbia
Canadian Institutes of Health Research (CIHR)

Withdrawn

VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU

Critical Care | Medical Device | User-Computer Interface | Physiologic Monitoring

Canada
Ciusss de L'Est de l'Île de Montréal
Canadian Institutes of Health Research (CIHR)

Recruiting

RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders (AC2)

Psychotic Disorders | Mental Health Disorder | Cannabis Use Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in Depression

Cognitive Impairment | Major Depressive Disorder | Cannabis Use

Canada
Ciusss de L'Est de l'Île de Montréal

Active, not recruiting

Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders (Avatar-CUD)

Psychotic Disorders | Mental Health Disorder | Cannabis Use Disorder

Canada
CHU de Quebec-Universite Laval
McGill University; Université de Sherbrooke

Recruiting

Medical Cannabis Against Chronic Musculoskeletal Pain: a Mixed Methods Study.

Musculoskeletal Pain | Cannabis Use

Canada
Laval University

Completed

Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome

Overweight | Metabolic Syndrome | Insulin Resistance | Endotoxemia | Non-Alcoholic Fatty Liver Disease | Microbiota

Canada
University of Calgary
GlaxoSmithKline; Canadian Institutes of Health Research (CIHR)

Completed

A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada

Vaccine Reaction | Hepatitis B | Non-Alcoholic Fatty Liver Disease

Canada
University of Calgary
Alberta Health services; University of Alberta

Completed

Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial (TNT)

Stroke | Epilepsy | Autoimmune Diseases | Endocrine System Diseases | Diabetes | Hematologic Diseases | Genetic Diseases, Inborn | Traumatic Brain Injury | Autism Spectrum Disorder | Respiratory Disease | Cardiac Disease | Metabolic Disease | Renal Disease | Neuro-Degenerative Disease | Fetal Alcohol Spectrum Disorders | Gastro-Intestinal Disorder

Canada
Centre hospitalier de l'Université de Montréal...
Ministere de la Sante et des Services Sociaux

Enrolling by invitation

A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC) (iCC)

Cannabis Use Disorder

Canada
Centre for Addiction and Mental Health

Completed

Virtual Mantram Program for Patients With PTSD and SUD

Post Traumatic Stress Disorder | Substance Use Disorders

Canada
Unity Health Toronto
University of Toronto; Toronto Public Health; Ontario College of Art and Design...

Withdrawn

Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER) (SOONER)

Opioid-Related Disorders | Opioid Use | Education | Opioid Withdrawal | Opioid Overdose | Resusitation

Canada
Centre for Addiction and Mental Health

Recruiting

A4i-O: A Platform for Complex Behavioral Health to Address OUD

Opioid-Related Disorders | Mental Health Wellness 1 | Mobile Phone Use | Comorbidities and Coexisting Conditions | Relationship, Professional Patient

Canada
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments (INITIATE)

Nicotine Dependence, Cigarettes | Nicotine Withdrawal

Canada
University of British Columbia

Withdrawn

The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit

Critical Care | Medical Device | User-Computer Interface | Physiologic Monitoring

Canada
Cukurova University

Completed

ESP Block in Pediatric Patients for Postoperative Analgesia (ESP1)

Quality of Life | Pain, Postoperative | Opioid Use

Turkey
Nova Scotia Health Authority
Queen Elizabeth II Health Sciences Centre Foundation; Research Nova Scotia; Killam...

Completed

Psychotherapy for Psychosis, Adverse Events, and Substance Misuse

Psychotic Disorders | Stress Disorders, Traumatic | Substance Use

Canada
M. Eugenia Socias
Canadian Institutes of Health Research (CIHR); Mayne Pharma International Pty... and other collaborators

Terminated

Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder (pRESTO)

Opioid-Related Disorders | Opiate Substitution Treatment | Morphine | Fentanyl | Methadone

Canada
Universidad de Granada

Active, not recruiting

Effect of Cannabidiol (CBD) on Vision and Driving

Cannabis Use

Spain
University of Calgary
Canadian Institutes of Health Research (CIHR)

Completed

Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease

Non-alcoholic Fatty Liver Disease

Canada
University of Western Ontario, Canada

Completed

Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic Fatty Liver Disease

Canada
McMaster University
Harvard Medical School (HMS and HSDM); The Hospital for Sick Children; Canadian... and other collaborators

Terminated

READYorNot[TM] Brain-Based Disabilities Trial

Epilepsy | Cerebral Palsy | Autism Spectrum Disorder | Spina Bifida | Fetal Alcohol Spectrum Disorders

Canada
Vancouver Infectious Diseases Centre
Gilead Sciences; Regina General Hospital

Unknown

STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY) (SINNR)

HIV | Illicit Drug User

Canada
Hoffmann-La Roche

Completed

Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe

Off-Label Use

Spain, France, Italy, United Kingdom, Germany
University of Toronto
Canadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated... and other collaborators

Unknown

Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk

Hypertension | Obesity | Cardiovascular Disease | Dyslipidemia | Prediabetes | Gout | Non-Alcoholic Fatty Liver Disease | Dysglycemia

Canada
Centre for Addiction and Mental Health

Recruiting

Effect of Extended Cannabis Abstinence on PTSD Symptoms (CANPOST)

PTSD | Cannabis Use | Cognitive Symptom | Comorbidities and Coexisting Conditions

Canada
Centre for Addiction and Mental Health
Canadian Psychiatric Research Foundation

Completed

Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia

Smoking | Schizophrenia | Schizoaffective Disorder | Psychosis | Nicotine Dependence | Schizophreniform Disorders

Canada
Johane Allard
Ontario HIV Treatment Network

Terminated

Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions

HIV Infections | Fatty Liver

Canada
University Health Network, Toronto

Recruiting

Reducing Opioid Use for Chronic Pain Patients Following Surgery (RECOUP)

Chronic Pain | Postoperative Pain | Opioid Dependence | Opioid Use

Canada
Vancouver Infectious Diseases Centre

Recruiting

Eliminating HCV Infection Among PWUD

Hepatitis C, Chronic | Drug Use

Canada
Tetra Bio-Pharma

Suspended

Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia (SERENITY)

Advanced Cancer | Cannabis Use | Cachexia; Cancer

Canada
Laval University

Completed

Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans

Overweight | Metabolic Syndrome | Insulin Resistance | Endotoxemia | Non-Alcoholic Fatty Liver Disease | Microtia

Canada
Johane Allard
Canadian Institutes of Health Research (CIHR); Canadian Liver Foundation; American...

Completed

Fatty Acids, Genes and Microbiota in Fatty Liver

Nonalcoholic Fatty Liver Disease | Steatosis | Nonalcoholic Steatohepatitis

Canada
McGill University Health Centre/Research Institute...

Active, not recruiting

Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD (Theratech)

Visceral Steatosis | Hiv | NAFLD

Canada
trueNorth Medical Centres
Gilead Sciences

Recruiting

Re-link HCV in Substance-Use Telemedicine Program

Hepatitis C

Canada
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Pharmacogenetics of Nicotine Addiction Treatment

Nicotine Addiction

United States, Canada
British Columbia Cancer Agency
National Cancer Institute (NCI); University of Cincinnati

Completed

Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum

Tobacco Use Disorder | Lung Cancer

Canada
Didier Jutras Aswad
Canadian Institutes of Health Research (CIHR)

Completed

A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse (OPTIMA)

Opioid Use Disorder

Canada
Indivior Inc.

Active, not recruiting

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

Moderate to Severe Opioid-use Disorder

United States, Canada
Stanford University
Mayo Clinic; University of British Columbia; Albert Einstein College of Medicine and other collaborators

Completed

Pain Control Following Sinus Surgery

Pain | Postoperative Pain | Sinusitis | Opioid Use | Opioid Abuse | Narcotic Use | Otolaryngologic Disease

United States, Canada
Université du Québec à Trois-Rivières
Université de Sherbrooke; Laval University; Université de Montréal; Université...

Recruiting

Integrative Couple Treatment for Gambling/Substance Use Disorder

Substance Use Disorders | Gambling Disorder

Canada
Karolinska Institutet
University of Copenhagen; Norwegian University of Science and Technology; University... and other collaborators

Completed

Nordic Gastric and Esophageal Tumor Study (NordGETS)

Cancer of the Esophagus | Drug Use | Cancer of Stomach

Sweden
McGill University Health Centre/Research Institute...
Merck Sharp & Dohme LLC

Completed

Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients

Fatty Liver | HIV | Nonalcoholic Steatohepatitis

Canada
University Health Network, Toronto
Novo Nordisk A/S

Enrolling by invitation

Semaglutide vs Sitagliptin

Diabetes Mellitus | NAFLD | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; Complications

Canada
Johane Allard
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery

Non-alcoholic Fatty Liver Disease | Morbid Obesity

Canada
McGill University Health Centre/Research Institute...
CIHR Canadian HIV Trials Network

Completed

Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E

HIV Mono Infection

Canada
Nova Scotia Health Authority

Recruiting

Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use (IMAGINE)

Schizophrenia | Bipolar Disorder | Major Depressive Disorder | Mental Illness | Psychosis | Cannabis Use

Canada
Lady Davis Institute

Completed

Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus

Lithium Use, Nephrogenic Diabetes Insipidus

Canada
Centre hospitalier de l'Université de Montréal...
Canadian Institutes of Health Research (CIHR); McGill University Health Centre... and other collaborators

Recruiting

Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis (QUS in NASH)

Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)

Canada
Health Sciences North Research Institute
North Shore Tribal Council

Completed

Evaluating the Integration of Indigenous Healing With Principals of Seeking Safety for Treatment of Indigenous Patients With a History of Trauma and Active Substance Use Disorder.

Substance Use Disorders | Post-Traumatic Stress Disorder | Intergenerational Trauma

Canada
John Sievenpiper
Canadian Institutes of Health Research (CIHR); Canada Research Chairs Endowment... and other collaborators

Unknown

Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk

Hypertension | Obesity | Cardiovascular Disease | Diabetes | Overweight | Metabolic Syndrome | Dyslipidemia | Kidney Injury | Prediabetes | Gout | Dysglycemia | Kidney Disease | Non-alcoholic Fatty Liver Disease (NAFLD)

Canada

Clinical Trials on Hazardous; Use, Alcohol in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations